<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: In the USA, atrophic <z:hpo ids='HP_0005263'>gastritis</z:hpo> and <z:hpo ids='HP_0012126'>gastric cancer</z:hpo> are rare, whereas <z:e sem="disease" ids="C0017168" disease_type="Disease or Syndrome" abbrv="GERD">gastro-oesophageal reflux disease</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e>) is common </plain></SENT>
<SENT sid="1" pm="."><plain><z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">Infection</z:e> with Helicobacter pylori, especially a CagA positive strain, is unusual in patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e>/<z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> in the USA </plain></SENT>
<SENT sid="2" pm="."><plain>AIM: To examine the relation between <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> and CagA positive H pylori in Colombia, a country with a high prevalence of CagA positive H pylori associated atrophic <z:hpo ids='HP_0005263'>gastritis</z:hpo> and <z:hpo ids='HP_0012126'>gastric cancer</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: Helicobacter pylori and CagA status was determined among Colombian patients with long segment <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> and a control group with simple H pylori <z:hpo ids='HP_0005263'>gastritis</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>Helicobacter pylori status was determined using a triple stain and CagA status was determined by immunohistochemistry using a specific rabbit anti-CagA serum </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: Gastric and oesophageal mucosal biopsies were obtained from 51 patients--39 men (mean age, 57.8 years; SD, 13.1) and 12 women (mean age, 51.8 years; SD, 14.4)--with documented long segment <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>The results were compared with 24 Colombian patients with H pylori <z:hpo ids='HP_0005263'>gastritis</z:hpo> without <z:e sem="disease" ids="C0014852" disease_type="Disease or Syndrome" abbrv="">oesophageal disease</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>Thirty two patients with <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> had active <z:e sem="disease" ids="C0850666" disease_type="Disease or Syndrome" abbrv="">H pylori infection</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>CagA status was evaluated in a subset of 23 H pylori infected patients with <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e>, and was positive in eight of these patients compared with 19 of 24 controls (p = 0.01) </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: Although most Colombian patients with <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> had <z:e sem="disease" ids="C0850666" disease_type="Disease or Syndrome" abbrv="">H pylori infection</z:e>, CagA positive <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infections</z:e> were unusual </plain></SENT>
<SENT sid="10" pm="."><plain>These data illustrate how consistent corpus <z:mp ids='MP_0001845'>inflammation</z:mp> reduces acid secretion, which prevents <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> among those with abnormal <z:e sem="disease" ids="C0017168" disease_type="Disease or Syndrome" abbrv="GERD">gastro-oesophageal reflux</z:e> barriers </plain></SENT>
</text></document>